Companies formed
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
GaitQ


Improving the lives of people living with Parkinson’s.
Incorporated in March 2020
Origin: Oxford University, Physiology, Anatomy and Genetics
Contact: Richard Auburn
Spintex Engineering


To develop commercially scalable manufacturing process for spinning spider silk.
Incorporated in January 2020
Origin: Oxford University, Zoology
Contact: Adam Workman
Living Optics
3D laser spectrometer and single shot hyperspectral imaging.
Incorporated in January 2020
Origin: Oxford University, Physics
Contact: Steve Silvey
2019
ORCA Computing


building a scalable, modular and flexible quantum computing platform.
Incorporated in December 2019
Origin: Oxford University
Ground Truth Labs
Mining large digital pathology datasets through a web platform that can manage a crowd sourced approach to annotation.
Incorporated in December 2019
Origin: Oxford University, IBME and NDM
Global Malaria Vaccinces
GyreOx

Lime Biosciences
Nucleome Therapeutics


Platform technology based on NG capture-c technique computational pipelines and experimental know-how.
Incorporated in July 2019
Origin: Oxford University, MRC Weatherall Institute of Molecular Medicine
Contact: Matthew Carpenter
Akrivia Health (Cristal Health)

Machine Discovery


Development and commercialisation of quantum physics, acceleration and optimisation software for intelligent computational R&D.
Incorporated in May 2019
Origin: Oxford University, Physics
Oxford Brain Diagnostics


Software and patented approach to differential diagnosis of cognitive diseases
Incorporated in April 2019
Origin: Oxford University, Nuffield Department of Clinical Neurosciences
MiroBio


A biologics company with a mission to treat a range of autoimmune and inflammatory disorders.
Incorporated in April 2019
Origin: Oxford University
Contact: Adam Stoten
Oxford Ionics


High performance quantum computing
Incorporated in April 2019
Origin: Oxford University, Physics
Asymmetric Suzuki Reactions (EnantiOx)


To develop compound libraries based on the asymmetric synthesis methodolofies.
Incorporated in March 2019
Origin: Oxford University, Chemistry
Rogue Interrobang


Strategy gaming and consultancy
Incorporated in March 2019
Origin: Oxford University, Linguistics
Contact: Chris Fellingham
2018
Cortex Organics


Focus on the synthesis of natural products.
Incorporated in December 2018
Origin: Oxford University, Chemistry
Oxstem Immuno


OxStem Immuno aims to develop small molecule drugs that augment macrophage efferocytosis in
vitro and enhance tissue repair in vivo. These therapies will supercede the need for cell transplantation
or cytokine therapy in the context of tissue repair for chronic wounds and a range of inflammatory
conditions.
Incorporated in December 2018
Origin: Oxford University, Department of Physiology, Anatomy and Genetics
Contact: Adam Workman
Oxstem Beta


OxStem Beta will generate novel therapies to stimulate formation of new beta cells in the pancreas
(neogenesis) by targeting pathways that are normally only active during development or following
pancreatic injury.
Incorporated in December 2018
Origin: Oxford University, Pathology
sOPHIa Oxford


A not for profit company providing a solution and accreditation to businesses that work to bring their workforce out of multidimensional poverty
Incorporated in November 2018
Origin: Oxford University, International Development
Contact: Mark Mann